Dexmedetomidine

WITHDRAWN · PHASE4 · Shivering, Dose Finding Study

Unable to start study.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.